Drugs / BNT3212
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07147348 | Aug 2025 → Nov 2027 expected | neoplastic disease or syndrome | BioNTech SE | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNT3212 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07147348 ↗ |